​

Funding Round

Series D - TISSIUM

Series D - TISSIUM

Investment Firm

Overview

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Announced Date

May 23, 2023

Funding Type

Series D

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorCathay Health
Participant InvestorFonds Stratégique d'Investissement
Participant InvestorCrédit Mutuel Innovation
Participant InvestorMérieux Equity Partners
Participant InvestorSofinnova Partners

Round Details and Background

TISSIUM raised $53847396 on 2023-05-23 in Series D

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 30, 2016
Debt Financing - TISSIUM
1-1.6M
Mar 17, 2016
Series A - TISSIUM
4-25.5M
Jan 20, 2015
Venture Round - TISSIUM
1-1.5M
Dec 09, 2013
Series A - TISSIUM
3-11.0M

Recent Activity

There is no recent news or activity for this profile.